Serial Number | 97042705 |
Word Mark | SURGE |
Filing Date | Thursday, September 23, 2021 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Wednesday, April 16, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, February 27, 2024 |
Goods and Services | Hydrogel for medical purposes; Natural biomaterial for delivery of immunotherapy; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; Natural intraoperative biomaterial for delivery of immunotherapy |
Goods and Services | Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy |
Goods and Services | Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing medical research and scientific research information in the fields of oncology and immunotherapy via a website |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, November 14, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Monday, November 14, 2022 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, November 14, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | SURGE THERAPEUTICS, INC. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | BROOKLINE, MA 02446 |
Party Name | SURGE THERAPEUTICS, INC. |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | BROOKLINE, MA 02446 |
Party Name | STIMIT CORPORATION |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Brookline, MA 02446 |
Event Date | Event Description |
Thursday, July 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, September 27, 2021 | NEW APPLICATION ENTERED |
Tuesday, October 26, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, November 3, 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Friday, June 24, 2022 | ASSIGNED TO EXAMINER |
Thursday, July 21, 2022 | NON-FINAL ACTION WRITTEN |
Thursday, July 21, 2022 | NON-FINAL ACTION E-MAILED |
Friday, October 21, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, October 21, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Saturday, October 22, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, November 14, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Monday, November 14, 2022 | EXAMINERS AMENDMENT E-MAILED |
Monday, November 14, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, November 14, 2022 | EXAMINER'S AMENDMENT ENTERED |
Friday, November 25, 2022 | SUSPENSION LETTER WRITTEN |
Friday, November 25, 2022 | LETTER OF SUSPENSION E-MAILED |
Friday, November 25, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, June 8, 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Friday, June 30, 2023 | NON-FINAL ACTION WRITTEN |
Friday, June 30, 2023 | NON-FINAL ACTION E-MAILED |
Friday, June 30, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, August 25, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Friday, August 25, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Friday, October 27, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Friday, October 27, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Friday, October 27, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, October 27, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, October 27, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, December 27, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, December 27, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, December 28, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, January 24, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, January 24, 2024 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, January 24, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, January 24, 2024 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, January 24, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, February 7, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, February 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, February 27, 2024 | PUBLISHED FOR OPPOSITION |
Monday, March 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, October 8, 2024 | SOU EXTENSION 1 GRANTED |
Wednesday, April 16, 2025 | SOU TEAS EXTENSION RECEIVED |
Wednesday, April 16, 2025 | SOU EXTENSION 2 FILED |
Wednesday, April 16, 2025 | SOU EXTENSION 2 GRANTED |
Wednesday, April 16, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, October 8, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, April 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, October 8, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, October 8, 2024 | SOU EXTENSION 1 FILED |